ArticleNeuro-oncology2015

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.

Robert W Rapkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.